Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7653)
All Articles published online
|
Publishing Process of This Article
|
Feb 8, 2017 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cholongitas E, Pipili C, Papatheodoridis GV. Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation. World J Hepatol 2017; 9(4): 180-190 [PMID: 28217256 DOI: 10.4254/wjh.v9.i4.180] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i4/180.htm |
| Number | Citing Articles |
| 1 |
Hosnieh Fathi, Andrew Clark, Nathan R. Hill, Geoffrey Dusheiko. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2820-z
|
| 2 |
Matt Driedger, Chrissi Galanakis, Curtis Cooper. Direct acting antiviral HCV treatment does not influence renal function. Medicine 2020; 99(22): e20436 doi: 10.1097/MD.0000000000020436
|
| 3 |
Geoffrey Dusheiko. Sherlock's Diseases of the Liver and Biliary System. 2018; : 436 doi: 10.1002/9781119237662.ch23
|
| 4 |
Evangelos Cholongitas, George V. Papatheodoridis. Hepatitis C: Care and Treatment. 2021; : 175 doi: 10.1007/978-3-030-67762-6_12
|
| 5 |
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran. Hepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
|
| 6 |
|
| 7 |
Jong Eun Yeon. Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL. Clinical and Molecular Hepatology 2018; 24(3): 278 doi: 10.3350/cmh.2018.1002
|
| 8 |
Larissa Sgaria Pacheco, Pedro Enrico Ventura, Roger Kist, Valter Duro Garcia, Gisele Meinerz, Cristiane Valle Tovo, Guido Pio Cracco Cantisani, Maria Lucia Zanotelli, Marcos Mucenic, Elizete Keitel. Real-world effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C virus in kidney and liver transplant recipients: experience of a large transplant center in Brazil. Revista do Instituto de Medicina Tropical de São Paulo 2023; 65 doi: 10.1590/s1678-9946202365059
|
| 9 |
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo. Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C. Anales de Pediatría 2019; 90(3): 141 doi: 10.1016/j.anpedi.2018.07.007
|
| 10 |
Hossein Poustchi, Sara Majd Jabbari, Shahin Merat, Amir‐Houshang Sharifi, Ali Akbar Shayesteh, Elahe Shayesteh, Mohammad Minakari, Mohammad Reza Fattahi, Maryam Moini, Fatemeh Roozbeh, Fariborz Mansour‐Ghanaei, Behrooz Afshar, Marjan Mokhtare, Taghi Amiriani, Masoomeh Sofian, Mohammad‐Hossein Somi, Shahram Agah, Iradj Maleki, Maryam Latifnia, Mojtaba Fattahi Abdizadeh, Ahmad Hormati, Masoud Khoshnia, Masoudreza Sohrabi, Zeinab Malekzadeh, Dorsa Merat, Reza Malekzadeh. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology 2020; 35(9): 1590 doi: 10.1111/jgh.14994
|
| 11 |
A. Oruc, A. Ersoy. Transplantation Opportunities of Hepatitis C Virus–Seropositive Patients on the Kidney Waiting List. Transplantation Proceedings 2018; 50(10): 3181 doi: 10.1016/j.transproceed.2018.04.044
|
| 12 |
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C. Clinical and Molecular Hepatology 2018; 24(3): 169 doi: 10.3350/cmh.2018.1004
|
| 13 |
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo. Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents. Anales de Pediatría (English Edition) 2019; 90(3): 141 doi: 10.1016/j.anpede.2018.07.004
|
| 14 |
Emine Parlak. Management of hepatitis C patients with kidney failure. Ortadoğu Tıp Dergisi 2019; 11(4): 577 doi: 10.21601/ortadogutipdergisi.479176
|